Capital International’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48,509
| Closed | -$4.48M | – | 153 |
|
|
2024
Q4 | $4.48M | Sell |
48,509
-18,042
| -27% | -$1.62M | 0.18% | 112 |
|
|
2024
Q3 | $5.58M | Buy |
66,551
+1,171
| +2% | +$89.4K | 0.24% | 97 |
|
|
2024
Q2 | $4.49M | Sell |
65,380
-539
| -0.8% | -$36K | 0.21% | 102 |
|
|
2024
Q1 | $4.83M | Buy |
65,919
+1,483
| +2% | +$114K | 0.23% | 102 |
|
|
2023
Q4 | $5.22M | Sell |
64,436
-211
| -0.3% | -$16.4K | 0.27% | 97 |
|
|
2023
Q3 | $4.84M | Buy |
64,647
+25,528
| +65% | +$1.96M | 0.28% | 98 |
|
|
2023
Q2 | $3.01M | Buy |
+39,119
| New | +$3.12M | 0.17% | 124 |
|
|
2021
Q2 | – | Sell |
-15,778
| Closed | -$1.02M | – | 164 |
|
|
2021
Q1 | $1.02M | Sell |
15,778
-4,053
| -20% | -$261K | 0.06% | 145 |
|
|
2020
Q4 | $1.16M | Hold |
19,831
| – | – | 0.07% | 143 |
|
|
2020
Q3 | $1.25M | Sell |
19,831
-8,935
| -31% | -$620K | 0.08% | 139 |
|
|
2020
Q2 | $2.21M | Sell |
28,766
-24,000
| -45% | -$1.84M | 0.21% | 95 |
|
|
2020
Q1 | $3.94M | Buy |
52,766
+39,186
| +289% | +$2.71M | 0.44% | 62 |
|
|
2019
Q4 | $882K | Buy |
13,580
+5,080
| +60% | +$331K | 0.09% | 124 |
|
|
2019
Q3 | $539K | Buy |
+8,500
| New | +$556K | 0.08% | 125 |
|
|
2019
Q1 | – | Sell |
-36,484
| Closed | -$2.28M | – | 138 |
|
|
2018
Q4 | $2.28M | Buy |
36,484
+20,029
| +122% | +$1.4M | 0.62% | 47 |
|
|
2018
Q3 | $1.27M | Sell |
16,455
-8,725
| -35% | -$659K | 0.4% | 74 |
|
|
2018
Q2 | $1.78M | Sell |
25,180
-3,552
| -12% | -$251K | 0.31% | 91 |
|
|
2018
Q1 | $2.17M | Buy |
28,732
+765
| +3% | +$60.8K | 0.39% | 76 |
|
|
2017
Q4 | $2M | Sell |
27,967
-88,790
| -76% | -$6.74M | 0.38% | 79 |
|
|
2017
Q3 | $9.46M | Sell |
116,757
-42,850
| -27% | -$3.28M | 0.62% | 59 |
|
|
2017
Q2 | $11.3M | Hold |
159,607
| – | – | 0.75% | 51 |
|
|
2017
Q1 | $10.8M | Sell |
159,607
-5,400
| -3% | -$380K | 0.71% | 54 |
|
|
2016
Q4 | $11.8M | Buy |
165,007
+24,000
| +17% | +$1.78M | 0.83% | 46 |
|
|
2016
Q3 | $11.2M | Sell |
141,007
-45,350
| -24% | -$3.68M | 0.79% | 48 |
|
|
2016
Q2 | $15.5M | Sell |
186,357
-8,733
| -4% | -$775K | 1.13% | 34 |
|
|
2016
Q1 | $17.9M | Sell |
195,090
-40,590
| -17% | -$3.66M | 1.16% | 31 |
|
|
2015
Q4 | $23.8M | Sell |
235,680
-23,300
| -9% | -$2.42M | 1.51% | 17 |
|
|
2015
Q3 | $25.4M | Sell |
258,980
-172,870
| -40% | -$19.2M | 1.69% | 17 |
|
|
2015
Q2 | $50.6M | Hold |
431,850
| – | – | 2.98% | 4 |
|
|
2015
Q1 | $42.4M | Sell |
431,850
-146,450
| -25% | -$14.9M | 2.58% | 6 |
|
|
2014
Q4 | $54.5M | Sell |
578,300
-570,800
| -50% | -$59M | 3.32% | 3 |
|
|
2014
Q3 | $122M | Sell |
1,149,100
-48,000
| -4% | -$4.7M | 7.61% | 1 |
|
|
2014
Q2 | $99.3M | Sell |
1,197,100
-249,900
| -17% | -$19.5M | 6.14% | 1 |
|
|
2014
Q1 | $103M | Sell |
1,447,000
-94,100
| -6% | -$7.38M | 6.42% | 1 |
|
|
2013
Q4 | $116M | Sell |
1,541,100
-187,100
| -11% | -$13M | 7.08% | 1 |
|
|
2013
Q3 | $109M | Sell |
1,728,200
-753,800
| -30% | -$45.1M | 7.12% | 1 |
|
|
2013
Q2 | $127M | Buy |
+2,482,000
| New | +$129M | 7.84% | 1 |
|
Other funds holding GILD
Capital International's GILD Position: Q1 2025 in Review
Capital International sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 48,509 shares — an estimated $4.48M sold.
Capital International first reported a position in GILD in Q2 2013 and held it in 37 quarters. The position peaked at $127M in Q2 2013. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Capital International reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- Capital International sold 48,509 Gilead Sciences shares in Q1 2025, an estimated $4.48M.
- Capital International first reported a position in Gilead Sciences in Q2 2013 and held it in 37 quarters.
- Capital International's Gilead Sciences position peaked at $127M in Q2 2013.
- 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Capital International's 13F filing for Q1 2025, filed 12 May 2025.